Thromboprophylaxis in carriers of antiphospholipid antibodies (APL) without previous thrombosis: “Pros” and “Cons”

Finazzi, 2001, The epidemiology of the antiphospholipid syndrome: who is at risk?, Curr Rheumatol Rep, 3, 271, 10.1007/s11926-001-0030-5

Giron-Gonzalez, 2004, Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals, J Rheumatol, 31, 1560

Ruiz-Irastorza, 2011, Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies, Lupus, 20, 206, 10.1177/0961203310395803

Erkan, 2007, Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals, Arthritis Rheum, 56, 2382, 10.1002/art.22663

Erkan, 2002, A cross sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome, Rheumatology, 41, 924, 10.1093/rheumatology/41.8.924

Hereng, 2008, Influence of aspirin on the clinical outcomes of 103 anti-phospholipid antibodies-positive patients, Lupus, 17, 11, 10.1177/0961203307084724

Rosove MH, Brewer PM. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern med 117:303–308.

Derksen, 1993, Patients with antiphospholipid antibodies and venous thrombosis should receive long-term anticoagulant treatment, Ann Rheum Dis, 52, 689, 10.1136/ard.52.9.689

Khamashta, 1995, The management of thrombosis in the antiphospholipid antibody syndrome, N Engl J Med, 332, 993, 10.1056/NEJM199504133321504

Finazzi, 1996, Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian registry, Am J Med, 100, 530, 10.1016/S0002-9343(96)00060-5

Ruffatti, 2011, Antiphospholipid Syndrome Study Group of Italian Society of Rheumatology. Risk factors for a first thrombotic events in antiphospholipid carriers: a prospective multicentre follow-up study, Ann Rheum Dis, 70, 1083, 10.1136/ard.2010.142042

Shah, 1998, Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients, Lupus, 7, 3, 10.1191/096120398678919624

Wahl, 2000, Prophylactic antithrombotic therapy for patients with or without antiphospholipid antibodies: do the benefit outweigh the risk? A decision analysis, Arch Intern Med, 160, 2042, 10.1001/archinte.160.13.2042

Erkan, 2001, High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin, Arthritis Rheum, 44, 1466, 10.1002/1529-0131(200106)44:6<1466::AID-ART242>3.0.CO;2-C

Tektonidou, 2009, Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies, Arthritis Rheum, 61, 29, 10.1002/art.24232

Kaiser, 2009, Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus: results from a large, multi-ethnic cohort, Ann Rheum Dis, 68, 238, 10.1136/ard.2008.093013

Tarr, 2007, Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up, Clin Rev Allergy Immunol, 32, 131, 10.1007/s12016-007-0009-8

Miyakis, 2006, International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome, J Thromb Haemost, 4, 295, 10.1111/j.1538-7836.2006.01753.x

Patrono, 2004, Platelet-active drugs: the relationship among dose, effectiveness and side effects. The seventh ACCP conference on antithrombotic and thrombolytic therapy, Chest, 126, 234S, 10.1378/chest.126.3_suppl.234S

Barbhaiya, 2011, Primary thrombosis prophylaxis in antiphospholipid antibody-positive patients: where do we stand ?, Curr Rheumat Rep, 13, 59, 10.1007/s11926-010-0149-3

Kaul, 2007, Assessment of the 2006 revised antiphospholipid syndrome classification criteria, Ann Rheum Dis, 66, 927, 10.1136/ard.2006.067314

Pengo, 2010, Clinical course of high-risk patients diagnosed with antiphospholipid syndrome, J Thromb Haemost, 8, 237, 10.1111/j.1538-7836.2009.03674.x